This activity constitutes Phase 1 of a possible two-part effort directed towards guiding future benefit-cost studies, ensuring greater consistency and comparability across studies, and enhancing the ...
Under the Trump administration, the Securities and Exchange Commission is in the process of revamping its approach to the cost-benefit analysis it performs in support of its regulatory actions. These ...
The intersection of artificial intelligence (AI) and healthcare presents a transformative frontier, particularly in the global fight against cancer. As healthcare systems worldwide grapple with rising ...
Arthur Grimes has previously received funding from the New Zealand Treasury to examine the social discount rate which is one input into CBAx. Arthur Grimes is a Senior Fellow of Motu Research, and is ...